Literature DB >> 9434269

Stereoselectivity of antibodies for the bioanalysis of chiral drugs.

P A Got1, J M Scherrmann.   

Abstract

The use of immunoassay techniques represents an alternative approach to the more common chromatographic methods for the determination of the concentrations of chiral drugs. In the development of the former technique, the inherent stereoselectivity of the antibodies used appears to be an important parameter to be studied. The structural features of the drug, including the environment around the asymmetric center, the flexibility of the molecule and the ability of the molecule to undergo racemization, contribute to the molecule's ability to be recognized by stereoselective antibodies. These parameters are intrinsic and can not be influenced by the investigator. On the other hand, other parameters can be modified to favor the raising of highly stereoselective antibodies. These include the synthesis of an appropriate hapten; the selection of an optimal spacer arm between the hapten and the carrier protein used for the immunization procedure; and the choice of appropriate immunization and antibody-screening procedures. The purification of antibodies using affinity chromatography may also facilitate the selection of stereoselective antibodies.

Mesh:

Substances:

Year:  1997        PMID: 9434269     DOI: 10.1023/a:1012161814494

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  43 in total

1.  Radioimmunoassay of nicotine.

Authors:  S Matsukura; N Sakamoto; H Imura; H Matsuyama; T Tamada; T Ishiguro; H Muranaka
Journal:  Biochem Biophys Res Commun       Date:  1975-05-19       Impact factor: 3.575

Review 2.  Monoclonal antibodies in hapten immunoassays.

Authors:  O N Chappey; P Sandouk; J M Scherrmann
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

3.  Stereoselectivity of a radioimmunoassay for the insecticide S-bioallethrin.

Authors:  K D Wing; B D Hammock
Journal:  Experientia       Date:  1979-12-15

4.  Monoclonal antibodies specific for beta-adrenergic ligands.

Authors:  S Chamat; J Hoebeke; A D Strosberg
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

5.  Morphine pharmacokinetics and pain assessment after intracerebroventricular administration in patients with terminal cancer.

Authors:  P Sandouk; A Serrie; M Urtizberea; M Debray; P Got; J M Scherrmann
Journal:  Clin Pharmacol Ther       Date:  1991-04       Impact factor: 6.875

6.  Stereospecific radioimmunoassays for d-pseudoephedrine in human plasma and their application to bioequivalency studies.

Authors:  J W Findlay; J T Warren; J A Hill; R M Welch
Journal:  J Pharm Sci       Date:  1981-06       Impact factor: 3.534

7.  Stereospecific radioimmunoassay of alpha-l-acetylmethadol (LAAM).

Authors:  K L McGilliard; G D Olsen
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

8.  Determination of 9 alpha, 11 beta-prostaglandin F2 by stereospecific antibody in various rat tissues.

Authors:  H Hayashi; S Ito; T Tanaka; M Negishi; H Kawabe; H Yokohama; K Watanabe; O Hayaishi
Journal:  Prostaglandins       Date:  1987-04

9.  Selective antibodies to propranolol enantiomers produced from a new conjugate.

Authors:  A Sahui-Gnassi; C Pham-Huy; H Galons; J M Warnet; J R Claude; H T Duc
Journal:  Chirality       Date:  1993       Impact factor: 2.437

Review 10.  Enantiospecific analysis: applications in bioanalysis and metabolism.

Authors:  A J Hutt; M R Hadley; S C Tan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jul-Sep       Impact factor: 2.441

View more
  7 in total

1.  Production and characterization of 22 monoclonal antibodies directed against S 20499, a new potent 5-HT1A chiral agonist: influence of the hapten structure on specificity and stereorecognition.

Authors:  P Got; E Raimbaud; C Bussey; G Caron; P A Carrupt; B Walther; A Bensussan; J M Scherrmann
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

2.  Flaxseed ingestion alters ratio of enterolactone enantiomers in human serum.

Authors:  Niina M Saarinen; Annika I Smeds; José L Peñalvo; Tarja Nurmi; Herman Adlercreutz; Sari Mäkelä
Journal:  J Nutr Metab       Date:  2010-05-05

3.  Development of enantioselective polyclonal antibodies to detect styrene oxide protein adducts.

Authors:  Shuijie Shen; Fan Zhang; Su Zeng; Ye Tian; Xiaojuan Chai; Shirley Gee; Bruce D Hammock; Jiang Zheng
Journal:  Anal Chem       Date:  2009-04-01       Impact factor: 6.986

4.  The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi.

Authors:  Vivi Joosten; Christien Lokman; Cees AMJJ Van Den Hondel; Peter J Punt
Journal:  Microb Cell Fact       Date:  2003-01-30       Impact factor: 5.328

Review 5.  Significance and challenges of stereoselectivity assessing methods in drug metabolism.

Authors:  Zhuowei Shen; Chuang Lv; Su Zeng
Journal:  J Pharm Anal       Date:  2015-12-21

6.  Conformational adaptability determining antibody recognition to distomer: structure analysis of enantioselective antibody against chiral drug gatifloxacin.

Authors:  Lanteng Wang; Wei Xie; Wenyang Jiao; Chijian Zhang; Xiangmei Li; Zhenlin Xu; Xin-An Huang; Hongtao Lei; Xing Shen
Journal:  RSC Adv       Date:  2021-12-13       Impact factor: 3.361

7.  Chiral drugs: an overview.

Authors:  Lien Ai Nguyen; Hua He; Chuong Pham-Huy
Journal:  Int J Biomed Sci       Date:  2006-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.